| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |